Why Ordinary Medical Records Can't Be Used for Settlement

Traditional medical records are descriptive: they document what happened (diagnoses, prescriptions, test results). Payers verify these records and pay accordingly.

The challenge with preventive interventions is that the core "service outcome" is disease not occurring. The payer's question isn't "did the intervention happen?" but "did it actually prevent disease?" — a causal inference problem, not a record verification problem.

Key Distinction:Ordinary health records can prove "participants' blood pressure decreased after the program." Billable evidence must prove "the decrease was caused by the intervention, not because healthier people self-selected into the program." This requires causal inference, not descriptive statistics.

Six Core Elements of Billable Evidence

Element 01

Intervention Description

Intervention type (lifestyle, follow-up, digital-health tools, etc.), duration, population characteristics, and data provenance. Medication or treatment content is managed separately by medical institutions under applicable rules.

Required
Element 02

Baseline Characteristics Comparison

Pre-matching baseline differences between treatment and control groups, SMD, proving group comparability.

Required
Element 03

PSM Matching Quality

Propensity score model, matching method (nearest neighbor/kernel), post-matching SMD improvement, caliper width.

Required
Element 04

Average Treatment Effect (ATT)

Average causal effect of the treatment group relative to matched controls, with 95% CI and p-value.

Required
Element 05

Health Outcome Metrics

Primary outcome (e.g., cardiovascular risk score) and secondary outcomes (blood pressure, lipids, hospitalization rate) changes.

Required
Element 06

Scope and Limitations

Applicable population characteristics, follow-up duration limits, unmeasured confounders declaration, AI-generated content disclaimer.

Required

Three Levels of Billable Evidence

Level 1

Group Trend Evidence

Pre/post statistical comparison without fully eliminating confounders. Suitable for annual reports and internal performance, not recommended for insurance settlement.

Level 2

PSM Causal Attribution Evidence

PSM helps reduce bias from observed confounding and reports ATT with confidence intervals. It can inform program evaluation and discussion by commercial insurers, employers, and partners; it does not control unobserved confounding.

Level 3

Multi-center Federated Real-world Study Evidence

Multi-institution, federated studies can expand the observable data base and should fully disclose governance, design, quality checks, and limitations. Drug or device registration submissions require separate work under applicable NMPA requirements.

Sample Report Structure

PSM Causal Attribution Evidence Report · ReHealth CoreLevel 2 · RWE
Intervention TypeCombined (Lifestyle + Digital Health)
Follow-up Duration12 months
Treatment Group NN = 248
Matched Control NN = 248 (1:1 Nearest Neighbor)
Post-match SMD (Mean)0.042 (<0.1, Good Quality)
Primary Outcome: Risk Score ReductionProject-specific effect estimate
95% CI[-0.112, -0.062]
Secondary: Systolic BP Change-4.3 mmHg (p = 0.007)

Frequently Asked Questions

How is billable evidence different from ordinary medical records?
Medical records are descriptive — they document what happened. Billable evidence is analytical — it proves that health changes are statistically attributable to the intervention itself, not natural recovery or placebo effects. This requires causal inference methods like PSM, not simple before/after comparisons.
Who can evaluate this kind of evidence?
Commercial health insurers, employers, medical institutions, and research partners may evaluate evidence packages under their own program rules. Adoption, pricing, and payment arrangements remain independent decisions under applicable policy, contracts, and processes; this page does not imply a unified public-insurance settlement mechanism.
What sample size does an evidence report require?
There is no fixed sample size for every project. The question, outcome incidence, available controls, covariate quality, and target precision all affect design. A statistical analysis plan should be defined before the project and disclose its sample-size rationale and limitations.

Related Concepts